Watrium has doubled its shareholding in Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer, through a private placement.
For more information, see the press release from Ultimovacs (Norwegian only).
Ultimovacs AS, Image: Charlotte Sverdrup
